Skip to content

Clinical value of high-flow nasal cannula oxygen therapy in the prevention of postoperative pulmonary complications in elderly patients with non-small cell lung cancer

Clinical value of high-flow nasal cannula oxygen therapy in the prevention of postoperative pulmonary complications in elderly patients with non-small cell lung cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063161
Enrollment
Unknown
Registered
2022-09-01
Start date
2022-09-15
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer (NSCLC)

Interventions

Experimental group:received nasal high flow humidified oxygen therapy, after surgery
Control group:recevied conventional oxygen therapy after surgery

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 60-80 years; 2. Sign informed consent; 3. The surgical method was VATS resection of lung lobe or lung segment; 4. Surgical resection (preoperative clinical stage I to IIIa); 5. Postoperative pathological diagnosis was NSCLC (8th TNM stage).

Exclusion criteria

Exclusion criteria: 1. Transfer to thoracotomy or intraoperative blood loss exceeding 1000ml; 2. Total lung resection or simultaneous bilateral lung surgery; 3. Transferred directly to the intensive care unit after the operation; 4. Receive any chemotherapy, immune or targeted treatment before surgery; 5. Refuse to participate in the study or drop out halfway.

Design outcomes

Primary

MeasureTime frame
rate of postoperative pulmonary complications;Anderson Symptom Scale (Lung Cancer Module);

Secondary

MeasureTime frame
6 minutes walk test;oxygenation index;Leicester Cough Questionnaire in Mandarin Chinese Version, LCQ-MC;Simplified Cough Symptom Score, sCSS;Modified Version of the British Medical Research Council Dyspnea Questionnaire;

Countries

China

Contacts

Public ContactHuang Ruizhen

Fujian Provincial Hospital

461510008@qq.com+86 591 88217440

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 22, 2026